An investment research firm wanted to prove AI could revolutionize drug development. So they teamed up with Anthropic to see whether an unreleased version of Claude could make scorpion antivenom. It couldn't. It came up
You are being forwarded to The Verge in a few seconds. Renegade Enterprises is a news aggregator — we credit, link, and attribute every story to its original publisher. If you are the rights holder and want this link removed, use our DMCA process.